OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Innovative, combinatorial and high-throughput approaches to degrader synthesis
Rebecca Stevens, James D. F. Thompson, Julie C. L. Fournier, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 4838-4861
Closed Access | Times Cited: 9
Rebecca Stevens, James D. F. Thompson, Julie C. L. Fournier, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 4838-4861
Closed Access | Times Cited: 9
Showing 9 citing articles:
Factors to Consider for Synthesis in 1536-Well Plates─An Amide Coupling Case Study for PROTAC Synthesis
Rebecca Stevens, Harry E. P. Palmer, Afjal H. Miah, et al.
The Journal of Organic Chemistry (2025)
Open Access
Rebecca Stevens, Harry E. P. Palmer, Afjal H. Miah, et al.
The Journal of Organic Chemistry (2025)
Open Access
DNA Tetrahedron-Driven Multivalent Proteolysis-Targeting Chimeras: Enhancing Protein Degradation Efficiency and Tumor Targeting
Shiqing Li, Tao Zeng, Zhixing Wu, et al.
Journal of the American Chemical Society (2025)
Closed Access
Shiqing Li, Tao Zeng, Zhixing Wu, et al.
Journal of the American Chemical Society (2025)
Closed Access
E3 ubiquitin ligase TRIM31: A potential therapeutic target
Nian-Hua Deng, Zhen Tian, Ying-Jiao Zou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116846-116846
Open Access | Times Cited: 3
Nian-Hua Deng, Zhen Tian, Ying-Jiao Zou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116846-116846
Open Access | Times Cited: 3
Next steps for targeted protein degradation
Mackenzie W. Krone, Craig M. Crews
Cell chemical biology (2024)
Closed Access | Times Cited: 3
Mackenzie W. Krone, Craig M. Crews
Cell chemical biology (2024)
Closed Access | Times Cited: 3
Advances in Targeted Therapies for Inflammatory Diseases and Cancer: Exploring Cellular Mechanisms and Therapeutic Strategies
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 758-760
Open Access | Times Cited: 2
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 758-760
Open Access | Times Cited: 2
To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives
Diana Castagna, Benoit Gourdet, Roland Hjerpe, et al.
Progress in medicinal chemistry (2024), pp. 61-160
Closed Access | Times Cited: 1
Diana Castagna, Benoit Gourdet, Roland Hjerpe, et al.
Progress in medicinal chemistry (2024), pp. 61-160
Closed Access | Times Cited: 1
Protein Degradation in Focus
David Zollman, Kirsten McAulay
Nature Chemical Biology (2024)
Closed Access | Times Cited: 1
David Zollman, Kirsten McAulay
Nature Chemical Biology (2024)
Closed Access | Times Cited: 1
Expanding the reaction toolbox for nanoscale direct-to-biology PROTAC synthesis and biological evaluation
Rebecca Stevens, Harry J. Shrives, Jenni Cryan, et al.
RSC Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 1141-1150
Closed Access
Rebecca Stevens, Harry J. Shrives, Jenni Cryan, et al.
RSC Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 1141-1150
Closed Access
Collaborative GSK–University of Strathclyde doctoral research and training programmes: Transforming approaches to industry–academia engagement
Laura C Paterson, P. G. Humphreys, Henry A. Kelly, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 11, pp. 104162-104162
Open Access
Laura C Paterson, P. G. Humphreys, Henry A. Kelly, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 11, pp. 104162-104162
Open Access
